Invivyd (IVVD) EBIT Margin Growth (1y) (2025)

Invivyd (IVVD) EBIT Margin Growth (1y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn - -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.67 Bn 466.88 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 122.32 Bn 115.07 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn -170.00
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn 1,049.00
9 Alnylam Pharmaceuticals 37.55 Bn 34.54 Bn 959.66 Mn 1,997.00
10 Invivyd 104.02 Mn -122.67 Mn 16.07 Mn 6,617.00

Historic Data

Download Data
DateValue
Dec 31, 2025 6,617.00
Sep 30, 2025 58,605.00
Jun 30, 2025 204,744.00